Overview

Flortaucipir 18F PET Imaging in BIOCARD Study

Status:
Terminated
Trial end date:
2018-08-17
Target enrollment:
Participant gender:
Summary
This study is designed to assess the imaging characteristics of Flortaucipir (18F-AV-1451) in subjects who participated in the Biomarkers of Cognitive Decline Among Normal Individuals (BIOCARD) study at Johns Hopkins University.
Phase:
Phase 1
Details
Lead Sponsor:
Avid Radiopharmaceuticals